Literature DB >> 22483845

Comparison of 3'-deoxy-3'-[18F]fluorothymidine PET and O-(2-[18F]fluoroethyl)-L-tyrosine PET in patients with newly diagnosed glioma.

Su Young Jeong1, Sang Moo Lim.   

Abstract

PURPOSE: The purpose of this prospective study was to clarify the value of FLT PET and FET PET for the noninvasive grading and prognosis of newly diagnosed gliomas.
MATERIALS AND METHODS: Twenty patients with newly diagnosed gliomas were investigated with FLT and FET PET before surgery. FLT and FET uptakes were assessed by the maximum standardized uptake (SUVmax) of tumor, and the ratio to uptake in the normal brain parenchyma (TNR). All tumors were graded by WHO system.
RESULTS: FLT PET detected all 17 high-grade gliomas (HGG) and did not detect all 3 low-grade gliomas (LGG). FET PET detected all 20 HGG and LGG regardless of grading. The average FLT SUVmax in HGG and LGG was 1.51 ± 0.72 and 0.30 ± 0.07, and the average FLT TNR in HGG and LGG was 5.52 ± 3.09 and 1.12 ± 0.14, respectively. The differences of FLT SUVmax and TNR between HGG and LGG were statistically significant (p=0.0069, p=0.0070). The average FET SUVmax in HGG and LGG was 2.68 ± 0.86 and 1.36 ± 0.15, and the average FET TNR in HGG and LGG was 2.31 ± 0.73 and 1.27 ± 0.12, respectively. The differences of FET SUVmax and TNR between HGG and LGG were statistically significant (p=0.0129, p=0.0095).
CONCLUSIONS: FET PET has higher sensitivity in detection of gliomas rather than FLT PET, but it seems that FLT PET is better than FET PET for noninvasive grading and predicting prognosis of newly diagnosed gliomas, considering high contrast of FLT and overlap of FET uptakes between HGG and LGG.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22483845     DOI: 10.1016/j.nucmedbio.2012.02.009

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  12 in total

1.  A comparison of PET imaging agents for the assessment of therapy efficacy in a rodent model of glioma.

Authors:  Shehzahdi S Moonshi; Romain Bejot; Zeenat Atcha; Vimalan Vijayaragavan; Kishore K Bhakoo; Julian L Goggi
Journal:  Am J Nucl Med Mol Imaging       Date:  2013-09-19

Review 2.  60 Years of Achievements by KSNM in Neuroimaging Research.

Authors:  Jae Seung Kim; Hye Joo Son; Minyoung Oh; Dong Yun Lee; Hae Won Kim; Jungsu Oh
Journal:  Nucl Med Mol Imaging       Date:  2022-01-15

3.  Radiosynthesis and biological evaluation of alpha-[F-18]fluoromethyl phenylalanine for brain tumor imaging.

Authors:  Chaofeng Huang; Liya Yuan; Keith M Rich; Jonathan McConathy
Journal:  Nucl Med Biol       Date:  2013-03-23       Impact factor: 2.408

4.  Multimodal imaging based on MRI and PET reveals [(18)F]FLT PET as a specific and early indicator of treatment efficacy in a preclinical model of recurrent glioblastoma.

Authors:  Aurélien Corroyer-Dulmont; Elodie A Pérès; Aurélie N Gérault; Ariel Savina; Fanny Bouquet; Didier Divoux; Jérôme Toutain; Méziane Ibazizène; Eric T MacKenzie; Louisa Barré; Myriam Bernaudin; Edwige Petit; Samuel Valable
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-11-05       Impact factor: 9.236

5.  [(18)F]-fluoro-L-thymidine PET and advanced MRI for preoperative grading of gliomas.

Authors:  S Collet; S Valable; J M Constans; E Lechapt-Zalcman; S Roussel; N Delcroix; A Abbas; M Ibazizene; M Bernaudin; L Barré; J M Derlon; J S Guillamo
Journal:  Neuroimage Clin       Date:  2015-05-29       Impact factor: 4.881

6.  An intra-individual comparison of MRI, [18F]-FET and [18F]-FLT PET in patients with high-grade gliomas.

Authors:  Martha Nowosielski; Matthew D DiFranco; Daniel Putzer; Marcel Seiz; Wolfgang Recheis; Andreas H Jacobs; Günther Stockhammer; Markus Hutterer
Journal:  PLoS One       Date:  2014-04-23       Impact factor: 3.240

Review 7.  Clinical PET/MRI in neurooncology: opportunities and challenges from a single-institution perspective.

Authors:  Lisbeth Marner; Otto M Henriksen; Michael Lundemann; Vibeke Andrée Larsen; Ian Law
Journal:  Clin Transl Imaging       Date:  2016-11-18

8.  Investigation of brain tumors using (18)F-fluorobutyl ethacrynic amide and its metabolite with positron emission tomography.

Authors:  Ying-Cheng Huang; Ho-Lien Huang; Chun-Nan Yeh; Kun-Ju Lin; Chung-Shan Yu
Journal:  Onco Targets Ther       Date:  2015-07-24       Impact factor: 4.147

9.  The use of longitudinal 18F-FET MicroPET imaging to evaluate response to irinotecan in orthotopic human glioblastoma multiforme xenografts.

Authors:  Mette K Nedergaard; Karina Kristoffersen; Signe R Michaelsen; Jacob Madsen; Hans S Poulsen; Marie-Thérése Stockhausen; Ulrik Lassen; Andreas Kjaer
Journal:  PLoS One       Date:  2014-06-11       Impact factor: 3.240

10.  (68)Ga-PRGD2 PET/CT in the evaluation of Glioma: a prospective study.

Authors:  Deling Li; Xiaobin Zhao; Liwei Zhang; Fang Li; Nan Ji; Zhixian Gao; Jisheng Wang; Peng Kang; Zhaofei Liu; Jiyun Shi; Xiaoyuan Chen; Zhaohui Zhu
Journal:  Mol Pharm       Date:  2014-08-11       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.